Plendil and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Plendil (felodipine), especially for people who are male, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Atelectasis when taking Plendil. It is created by eHealthMe based on reports of 4,897 people who have side effects when taking Plendil from the FDA, and is updated regularly.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,443 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Jul, 26, 2026

4,897 people reported to have side effects when taking Plendil.
Among them, 50 people (1.02%) have Atelectasis.

Among these 50 people:

What is the gender of people who have Atelectasis when taking Plendil? *

female: 32 %
male: 68 %

What is the age of people who have Atelectasis when taking Plendil? *

What are other drugs people take besides Plendil? *

What are other side effects people have besides Atelectasis? *

Pain: 37 people, 74.00%
Stress And Anxiety: 37 people, 74.00%
Nausea (feeling of having an urge to vomit): 32 people, 64.00%
Headache (pain in head): 31 people, 62.00%
Chest Pain: 28 people, 56.00%
Infection: 28 people, 56.00%
Exostosis (formation of new bone on the surface of a bone): 27 people, 54.00%
Cardiac Failure Congestive: 27 people, 54.00%
Injury: 27 people, 54.00%
Cellulitis (infection under the skin): 27 people, 54.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 21 people, 42.00%
Trismus (reduced opening of the jaws): 17 people, 34.00%
Pain: 9 people, 18.00%
Bone Disorder: 4 people, 8.00%
Type 2 Diabetes: 2 people, 4.00%
Lung Squamous Cell Carcinoma Stage Iii (lung cancer has spread to lymph nodes on the same side of the chest as the tumour. the lymph nodes with cancer are near the sternum (chest bone) or where the bronchus enters the lung): 2 people, 4.00%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 2.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 2.00%
Hepatitis B: 1 person, 2.00%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Plendil and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plendil:

Plendil (4,990 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,443 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,636 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felodipine (the active ingredients of Plendil) and Plendil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.